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ALTHOUGH serum ferritin concentration
usually reflects body iron stores in patients
with iron deficiency and overload (Addison
et at., 1972), the relationship is lost in a
variety of pathological conditions. Hyper-
ferritinaemia without iron overload occurs
with chronic inflammation (Zucker et al.,
1974), in acute and chronic liver disease
(Martin et al., 1971; Prieto et al., 1975) and
in a variety of human malignancies in-
cluding breast cancer (Buffe et al., 1968;
Jones etal., 1973; Niitsu etal., 1975; Moriet
al., 1975; Marcus&Zinberg, 1975), suggest-
ing that serum ferritin may have a role as
a tumour index substance. In this respect,
it has been suggested that measurement of
serum ferritin concentration may be useful
in the follow-up of patients with certain
malignancies, to help assess residual
tumour mass (Wahren et al., 1977). Whilst
studying patients with breast cancer
undergoing treatment, we noticed that,
contrary to expectation, the concentration
of serum ferritin often increased in the
immediate postoperative period. This
stimulated a more detailed study ofserum
ferritin concentration aroundthe operative
period in patients with breast cancer.
Fifty female patients aged 33-76 years
who presented with Stage I, II or III
breast cancer were studied. Stage was
determined by clinical examination, and
the presence ofsystemic metastatic disease
was excluded as far as possible by chest
X-ray, radiological skeletal survey and
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radioisotope bone scan. All patients re-
ceived a Patey mastectomy, or a simple
mastectomy with or without clearance
ofaxillary lymphatics. None ofthepatients
received a transfusion of blood or blood
products in the perioperative period.
Blood was taken for measurement of
serum ferritin concentration, no more than
3 days preoperatively, and postoper-
tively on the 1st, 3rd, 5th, 8th and finally
between the 21st and 35th days, although
samples for each postoperative sampling
day were not obtained from every patient.
Serum ferritin concentration was measured
using a 2-site immunoradiometric assay
(Miles et al., 1974) with guinea-pig anti-
body to human liver ferritin. The normal
range of serum ferritin concentration in
51 adult females in our laboratory is 8-
177 jtg/l.
Serum ferritin concentrations on each
of the postoperative days were compared
with the preoperative values using a t test
for paired data. Also, the preoperative
concentration of serum ferritin was taken
as 100, and each value measured in the
postoperative period was expressed and
shown graphically, relative to this stan-
dard.
Ofthe 50 patients studied, 6 had Stage I
disease (tumour of 2 cm or less in its
greatest dimension and confined to the
breast), 32 Stage II (tumour of 2-5 cm in
its greatest dimension confined to the
breast or any tumour up to 5 cm with
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TAABLE.-Mean (± s.e.) serum ferritin concentrations in Groups A and B, and comparison
ofpre- with postoperative values in each patient using a t testfor paired data
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moveable homolateral axillary lymph
nodes considered to contain growth) and
12 Stage III (tumour > 5 cm in its greatest
dimension confined to the breast, or a
tumour of any size with direct extension
to chest wall or skin or with homolateral
axillary nodes fixed to one another or to
other structures and considered to contain
growth). In 29 patients (Group A) the
preoperative serum ferritin concentration
was normal (range 20-170 Hug/l) and in 21
(Group B) it was raised (range 233-830
ug/l). Relating the values to clinical stag-
ing showed concentration raised in one/6
Stage I (1677%), 13/22 Stage II (59 1%)
and 7/12 Stage III patients (59/30o). Of
all patients studied, 45/50 (90%o) showed
an immediate postoperative rise in serum
ferritin concentration. Serum ferritin con-
centrations measured pre- and postopera-
tively in Groups A and B are shown in the
Table, and the variation in serum ferritin
concentration in the 2 groups is shown in
the Figure.
Of Group A, 26 patients showed a post-
operative rise in serum ferritin concentra-
tion (range 30*6%-548-6o). In 12 ofthese,
it rose above normal range and returned
to normal in 10 by the 8th postoperative
day, but remained high in 2 over the 21st
and 35th days. Three patients showed no
significant change in concentration.
Of Group B, 19 patients showed a post-
operative rise in serum ferritin concentra-
tion (range 7.3%-87%) and remained
higher on the 5th postoperative day, but
by the 21st and 35th day it was sig-
nificantly below the preoperative level.
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FIG. Aean (+ s.e.) serum ferritin coneentra-
tions in Groups A and B expressed as a
percentage of the preoperativTe value.
Two patients showed no significant change
in concentration.
Although well recorded, the cause of
hyperferritinaemia in malignancy is un-
known, but tumour secretion of ferritin or
ferritin released from normal tissues (e.g.
liver) as a result of tumour presence are
possibilities. Ferritins are a family of
isomeric proteins, and different tissues
have different isoferritin profiles. Ferritin
from neoplastic tissue, whilst sharing
several isoferritins with normal tissues,
includes isoferritins which are more acidic
and immunologically distinct from adult
liver and spleen ferritin (Drysdale &
Singer, 1974) and attempts to measure
tumour-specific acidic isoferritins in the
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serum of patients with malignant disease
have been made (Hazard & Drysdale,
1977). This study used antibody raised
against human liver isoferritins but it
would not differentiate between tumour
and normal tissue ferritin.
The preoperative hyperferritinaemia
found in patients in this study could rep-
resent tumour secretion of ferritin, and it
is possible that the significant postopera-
tive fall in serum ferritin concentration
is due to reduction ofthe tumour mass, but
the possibility that removal of inflam-
matorytissueisacausecannotbeexcluded.
In this respect, serum ferritin concentra-
tion has also been shown to be raised in
patients with infection (Lipschitz et al.,
1974) and to fluctuatewith disease activity
in juvenile chronic polyarthritis (Craft
etal., 1977), thusbehavinglike otheracute-
phase reactant proteins such as fibrinogen
and haptoglobin. This would explain the
rise in serum ferritin concentration in the
postoperative period, ferritin being re-
leased from normal tissues in response to
surgery. This would be supported by the
bigger rise in Group A patients than in
Group B, who may be considered to have
an already established inflammation caus-
ing the preoperative hyperferritinaemia.
We have demonstrated a raised serum
ferritin concentration preoperatively in
21/50 (42%) ofpatients with breast cancer
without detectable systemic metastasis,
and a significant postoperative rise in 90%
ofpatients studied, althoughwe are unsure
ofthe cause. The effect ofsurgeryindicates
that specimens taken in the immediate
postoperative period may give inflated
values and emphasizesthe needfor caution
in interpreting serum ferritin concentra-
tion measured with an anti-liver ferritin
antibody, in both the assessment of body
iron stores and as a measure of tumour
mass. The development of a more specific
assay for the tumour ferritin in question
might answer some questions raised by
these data.
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